Literature DB >> 12270598

Recombinant dengue virus type 2 envelope/hepatitis B surface antigen hybrid protein expressed in Pichia pastoris can function as a bivalent immunogen.

Himani Bisht1, Dipti A Chugh, Manoj Raje, S Swaminathan Swaminathan, Navin Khanna.   

Abstract

A truncated version of the dengue virus type 2 envelope protein (Den2E) encoding the first 395 amino acid (aa) residues, and Den2E fused in-frame with the full-length 226-aa hepatitis B surface antigen (Den2E-HBsAg) protein were expressed in the methylotrophic yeast, Pichia pastoris. Both the recombinant proteins showed evidence of the capacity to form high molecular weight aggregates. Electron microscopic analysis of the purified proteins showed that while Den2E displayed an amorphous morphology, Den2E-HBsAg existed as well-structured virus-like particles (VLPs). Using immuno-gold electron microscopy, these VLPs were demonstrated to contain both components of the Den2E-HBsAg hybrid protein. Seroanalysis showed that the hybrid VLPs could function in vivo as bivalent immunogens, which could elicit immune responses directed against both components of the hybrid protein, as evidenced by ELISA, immunoprecipitation and immunofluorescence data. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12270598     DOI: 10.1016/s0168-1656(02)00181-5

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  8 in total

1.  Replication-defective adenoviral vaccine vector for the induction of immune responses to dengue virus type 2.

Authors:  Smita Jaiswal; Navin Khanna; S Swaminathan
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Recombinant dengue virus-like particles from Pichia pastoris: efficient production and immunological properties.

Authors:  Wenquan Liu; Hanning Jiang; Junmei Zhou; Xiaomeng Yang; Yunxia Tang; Danyun Fang; Lifang Jiang
Journal:  Virus Genes       Date:  2009-11-03       Impact factor: 2.332

3.  Expression in Pichia pastoris and immunological evaluation of a truncated Dengue envelope protein.

Authors:  Iris Valdés; Lisset Hermida; Aída Zulueta; Jorge Martín; Ricardo Silva; Mayling Alvarez; María G Guzmán; Gerardo Guillén
Journal:  Mol Biotechnol       Date:  2007-01       Impact factor: 2.695

4.  Immunogenic Subviral Particles Displaying Domain III of Dengue 2 Envelope Protein Vectored by Measles Virus.

Authors:  Indira S Harahap-Carrillo; Ivonne Ceballos-Olvera; Jorge Reyes-Del Valle
Journal:  Vaccines (Basel)       Date:  2015-07-03

Review 5.  Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.

Authors:  Emily M Plummer; Marianne Manchester
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010-09-24

Review 6.  Virus-like particles: passport to immune recognition.

Authors:  Elizabeth V L Grgacic; David A Anderson
Journal:  Methods       Date:  2006-09       Impact factor: 3.608

Review 7.  Dengue in India.

Authors:  Nivedita Gupta; Sakshi Srivastava; Amita Jain; Umesh C Chaturvedi
Journal:  Indian J Med Res       Date:  2012-09       Impact factor: 2.375

8.  Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies.

Authors:  Shailendra Mani; Lav Tripathi; Rajendra Raut; Poornima Tyagi; Upasana Arora; Tarani Barman; Ruchi Sood; Alka Galav; Wahala Wahala; Aravinda de Silva; Sathyamangalam Swaminathan; Navin Khanna
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.